Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

853 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An open-label, randomized, controlled trial on the benefit of β-hydroxy-β-methyl butyrate, l-arginine, l-glutamine combination beverages and locomotion training as supportive care for the treatment of unresectable hepatocellular carcinoma using lenvatinib: A pilot study (HELLO study).
Naganuma A, Makita F, Sugimoto R, Kikuchi M, Furuta K, Iwamoto S, Sakamori R, Kouno H, Ario K, Yatsuhashi H. Naganuma A, et al. Among authors: iwamoto s. Clin Nutr ESPEN. 2024 Dec 13:S2405-4577(24)01550-X. doi: 10.1016/j.clnesp.2024.12.005. Online ahead of print. Clin Nutr ESPEN. 2024. PMID: 39675424
Efficacy of GPE- strain live attenuated vaccine and CP7_E2alf strain recombinant live vaccine (marker vaccine) against Japanese epidemic classical swine fever virus isolated in 2019 and DIVA discrimination ability of the marker vaccine.
Yamashita M, Iwamoto S, Ochiai M, Sudo K, Nagasaka T, Saito A, Kozasa T, Omatsu T, Mizutani T, Yamamoto K. Yamashita M, et al. Among authors: iwamoto s. Res Vet Sci. 2025 Jan;182:105484. doi: 10.1016/j.rvsc.2024.105484. Epub 2024 Nov 28. Res Vet Sci. 2025. PMID: 39622177 Free article.
Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.
Ueno M, Takeda H, Takai A, Morimura H, Nishijima N, Iwamoto S, Okuyama S, Umeda M, Seta T, Ikeda A, Goto T, Miyamoto S, Kayahara T, Uenoyama Y, Matsumura K, Nakano S, Mishima M, Inuzuka T, Eso Y, Takahashi K, Marusawa H, Osaki Y, Hatano E, Seno H. Ueno M, et al. Among authors: iwamoto s. J Gastroenterol. 2024 Dec;59(12):1119. doi: 10.1007/s00535-024-02159-y. J Gastroenterol. 2024. PMID: 39432084 Free PMC article. No abstract available.
Novel cell spheroid culture method using Medaka dried fish powder.
Sakumoto T, Narita T, Morito S, Nishiyama M, Hashiguchi M, Mine Y, Iwamoto S, Toda S, Aoki S. Sakumoto T, et al. Among authors: iwamoto s. Heliyon. 2024 Sep 26;10(19):e38418. doi: 10.1016/j.heliyon.2024.e38418. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39397939 Free PMC article.
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.
Ueno M, Takeda H, Takai A, Morimura H, Nishijima N, Iwamoto S, Okuyama S, Umeda M, Seta T, Ikeda A, Goto T, Miyamoto S, Kayahara T, Uenoyama Y, Matsumura K, Nakano S, Mishima M, Inuzuka T, Eso Y, Takahashi K, Marusawa H, Osaki Y, Hatano E, Seno H. Ueno M, et al. Among authors: iwamoto s. J Gastroenterol. 2024 Dec;59(12):1107-1118. doi: 10.1007/s00535-024-02150-7. Epub 2024 Sep 18. J Gastroenterol. 2024. PMID: 39289234 Free PMC article.
[Core values and competencies of public health nurses: A Delphi survey].
Okamoto R, Kishi E, Matsumoto T, Dai Y, Murashima S, Asahara K, Saeki K, Arakida M, Iguchi A, Izumi H, Iwamoto S, Endo M, Karakawa Y, Sakata S, Furuhashi Y, Maeda K, Matsubara M, Mitsumori Y, Iwasaki-Motegi R, Yoshimura F. Okamoto R, et al. Among authors: iwamoto s. Nihon Koshu Eisei Zasshi. 2024 Sep 13. doi: 10.11236/jph.24-026. Online ahead of print. Nihon Koshu Eisei Zasshi. 2024. PMID: 39284724 Free article. Japanese.
Prevention of Recurrent Spontaneous Preterm Delivery Using Probiotics (Clostridium butyricum, Enterococcus faecium, and Bacillus subtilis; PPP Trial): Protocol for a Prospective, Single-Arm, Nonblinded, Multicenter Trial.
Yoneda S, Kobayashi T, Kikuchi K, Iwamoto S, Teramoto T, Chujo D, Otsuki K, Nakai A, Saito S. Yoneda S, et al. Among authors: iwamoto s. JMIR Res Protoc. 2024 Sep 9;13:e59928. doi: 10.2196/59928. JMIR Res Protoc. 2024. PMID: 39250784 Free PMC article.
853 results